The North American Sleep Apnea Market is Expected to Reach $235.9 Million in 2019 - A Report by MicroMarket Monitor

Share Article

The North American Sleep Apnea Market is expected to grow, due to the growing patient pool of sleep Apnea. http://www.micromarketmonitor.com/market/north-america-sleep-apnea-devices-2284049215.html

MicroMarket Monitor

MicroMarket Monitor

Key Players in the North American sleep apnea market are Philips Respironics, ResMed, Inc., Fisher & Paykel Healthcare, Carefusion, Corp., DeVilbiss Healthcare, Weinmann Medical Devices, Natus Medical

The North American sleep apnea market report defines and segments the concerned market in North America with analysis and forecast of revenue. The sleep apnea market in North America is expected to reach $235.9 million in 2019, at a CAGR of 4.3% from 2014 to 2019

Browse through the TOC of North American Sleep Apnea Market for an analysis of industry trends and segments, with the help of various tables and figures.
http://www.micromarketmonitor.com/market/north-america-sleep-apnea-devices-2284049215.html

The sleep apnea diagnosis and treatment pattern in North America has changed dramatically in the recent years. As per a survey conducted by Centers for Disease Control and Prevention (CDC) in 2010, 36.0% of the adults in the U.S. were obese and nearly 42.0% are projected to become obese by the year 2030. Obesity is a major cause of sleep apnea in adults, as the increase in a person’s Body Mass Index (BMI) directly leads to an increased risk of developing sleep apnea in that person. Therefore, the rise in the obese population is likely to add to the pool of sleep apnea patients. The continuously growing sleep apnea patient base is a key factor that is driving the global sleep apnea device market. About 100 million people worldwide are suspected to have obstructive sleep apnea. Sleep apnea is more prevalent in males than females, as 4.0% of the global male population and 2.0% of the female population suffer from OSA (Obstructive Sleep Apnea).

Early buyers will receive 10% customization on this report.

http://www.micromarketmonitor.com/contact/2284049215-request_for_customization.html

The gradually increasing awareness regarding sleep apnea and available diagnostic and therapeutic options are significant factors that are expected to drive the growth of this market. In the recent years, people have become more aware of sleep-related disorders like sleep apnea. This has led to the major healthcare providers like Philips Respironics and ResMed to actively engage in the research and development of devices related to these disorders, which has consequently resulted in the growth of the sleep apnea market in this region.

Speak to Analyst @http://www.micromarketmonitor.com/contact/2284049215-speak_to_analyst.html

The North American sleep apnea market is segmented and forecast on the basis of its products and segments. The market is further divided into two segments, namely Diagnostic and Therapeutic devices. The Diagnostic devices are categorized as Polysomnography (PSG) Devices, Respiratory Polygraphs, Two Channel Screening Devices (Nasal Flow Sensors, SPO2), Single Channel Screening Devices (Pulse Oximeters), and Actigraphy Systems. The Therapeutic devices include Positive Airway Pressure (PAP) Devices, Facial Interfaces, Adaptive Servo-Ventilation, Airway Clearance Systems, Oxygen Devices, Accessories, and Oral Appliances.

The report also analysis major countries, such as the U.S., Canada, And Mexico. The market is segmented and analyzed further on the basis of major end-users of these devices.

This report includes the market share and value chain analyses, along with the market metrics, such as drivers, restraints, and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of the key players in the market, including major companies of the market.

Related Reports:

Global Respiratory & Anesthesia Devices Market

The Global Respiratory & Anesthesia Devices Market, mainly driven by geriatric population and increasing prevalence of Chronic Obstructive Pulmonary Diseases (COPDs) and Obstructive Sleep Apnea (OSA) accompanied by rapid rise in the number of surgical procedures worldwide, was valued at $12.2 billion in 2013 and is expected to reach $19.5 billion by 2018, at a CAGR of 9.8%, for the given period. The Respiratory Devices market constitutes the largest segment accounting for around 59% of the Respiratory & Anesthesia Devices market.

http://www.micromarketmonitor.com/market-report/respiratory-anesthesia-devices-reports-6549062656.html

About MicroMarket Monitor :

MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.

Contact:
Mr. Chandrasekhar K.
5601 Bridge Street
Suite 300
Fort Worth, TX 76112
Tel: +1-888-502-0539
Email: sales(at)micromarketmonitor(dot)com
Connect with us on LinkedIn at http://www.linkedin.com/company/micromarketmonitor.

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Mr. Chandrasekhar K.
@mmarketmonitor
Follow >
Micro Market Monitor
Like >
Visit website